# Synchroneuron

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synchroneuron

- Industry: Biotechnology
- Headquarters: Waltham, US
- Total disclosed funding: $26M
- Latest round: Series B (Jul 2, 2014)
- Investors on record: 1

## About

Synchroneuron biopharmaceutical company that develops new therapies for tardive dyskinesia (TD) and other related movement disorders.

## Funding rounds

- Series B, Jul 2, 2014, $20M — 5Y Capital
- Series A, Feb 7, 2012, $6M — 5Y Capital

## Investors

- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A, Series B